Accurate identification of immunogenic cancer epitopes remains a central challenge in immuno-oncology. The Cancer Epitope Database and Analysis Resource (CEDAR, https://cedar.iedb.org/) was developed to provide comprehensive curation of experimentally validated epitopes and to foster the development of computational tools tailored to the cancer context. Recently, we released a suite of cancer-specific tools and analysis pipelines as part of the https://nextgen-tools.iedb.org/ platform, enabling users to generate, evaluate, and prioritize candidate T cell epitopes in a modular framework. Here, we present the design and functionality of these tools, describe their core methodologies, provide guidance for their use, and illustrate how they can be integrated into end-to-end pipelines. We highlight applications in cancer immunology and personalized immunotherapy by presenting practical use cases.
Carri et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: